<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01005940</url>
  </required_header>
  <id_info>
    <org_study_id>2009H0131</org_study_id>
    <nct_id>NCT01005940</nct_id>
  </id_info>
  <brief_title>Dental Device for Treatment of Sleep Apnea</brief_title>
  <acronym>OSA-MAD</acronym>
  <official_title>Health Outcomes of Treatment of Obstructive Sleep Apnea With Dental Devices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ulysses Magalang MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to see if treatment of obstructive sleep apnea (OSA) with a&#xD;
      mandibular advancement device (MAD) shows an increase in the quality of life. Many patients&#xD;
      prefer to call them mandibular advancers, jaw advancers, jaw advancement splints, jaw&#xD;
      advancement devices, anti-snoring mouthpieces, or oral appliances for the treatment of&#xD;
      snoring and mild to moderate obstructive sleep apnea. The investigators will also see how&#xD;
      helpful the mandibular advancement device is on insulin resistance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with obstructive sleep apnea (OSA) will be included in this prospective controlled&#xD;
      trial. OSA patients who are unable to tolerate CPAP or refuse CPAP(Continuous positive airway&#xD;
      pressure) (and who are deemed appropriate by their attending physician for dental device&#xD;
      treatment of OSA will be randomized to a control group (no MAD treatment) or to active MAD&#xD;
      therapy.&#xD;
&#xD;
      Epidemiologic studies suggest that OSA is associated with insulin resistance independent of&#xD;
      other known risk factors such as obesity. The cyclic intermittent hypoxia in OSA is the&#xD;
      primary stimulus that leads to insulin resistance, a primary risk factor for the development&#xD;
      of type 2 diabetes. There is an association between the level of hypoxic stress in OSA and&#xD;
      insulin resistance.&#xD;
&#xD;
      The overall hypothesis to be tested is that treatment of OSA with MAD will improve insulin&#xD;
      sensitivity, increase levels of HMW (High-molecular- weight) adiponectin, and improve&#xD;
      psychological adjustment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment of OSA with mandibular advancement device results in improvements in insulin sensitivity</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment of OSA with mandibular advancement device increases the levels of high-molecular-weight adiponectin in the circulation</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment of OSA with mandibular advancement device improves psychological adjustment.</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <arm_group>
    <arm_group_label>Mandibular advancement device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject is evaluated when receiving intervention with mandibular advancement device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No mandibular advancement device</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subject is evaluated when not receiving treatment with mandibular advancement device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mandibular advancement device</intervention_name>
    <description>Mandibular advancement device made to subject specific specifications</description>
    <arm_group_label>Mandibular advancement device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Apnea-hypopnea index (AHI) of at least 20 events/hr based on overnight polysomnography&#xD;
&#xD;
          -  &gt; 18 years of age&#xD;
&#xD;
          -  Unable to tolerate or refuse CPAP treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known diabetes mellitus&#xD;
&#xD;
          -  Body mass index (BMI) &gt; 45 kg/m2&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Known congestive heart failure&#xD;
&#xD;
          -  Use of illicit drugs&#xD;
&#xD;
          -  Excessive alcohol consumption, defined as:&#xD;
&#xD;
               -  More than 3 glasses of wine a day&#xD;
&#xD;
               -  More than 3 beers a day&#xD;
&#xD;
               -  More than 60 mL of hard liquor a day&#xD;
&#xD;
          -  Room air oxyhemoglobin saturation &lt; 90%&#xD;
&#xD;
          -  Use of home oxygen&#xD;
&#xD;
          -  Use of corticosteroids&#xD;
&#xD;
          -  Unable to give voluntary consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulysses Magalang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 30, 2009</study_first_submitted>
  <study_first_submitted_qc>October 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2009</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Ulysses Magalang MD</investigator_full_name>
    <investigator_title>Professor-Clinical</investigator_title>
  </responsible_party>
  <keyword>Sleep Apnea Syndromes</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Mandibular advancement device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

